For example, CYP2W1, highly expressed in CRC and HNSCC models, represents an attractive target for prodrug activation strategies [16, 27], whereas CYP1B1 overexpression in HNSCC may guide selective inhibitor development. The gene discussed is CYP2W1; the disease is head and neck squamous cell carcinoma.